Britain's Department of Health has chosen GlaxoSmithKline's cervical cancer vaccine Cervarix for the country's human papillomavirus immunization programme ahead of rival Gardasil.

The vaccine offers immunity to the strains of a virus which cause 70 percent of cases. It protects against two strains of human papillomavirus

A synthetic vaccine for human papillomavirus that can be delivered as a nasal spray has been successfully tested on mice, researchers say. The new vaccine would be able to offer protection against different strains of HPV, the source of the most common sexually transmitted disease in the United States and a cause of cervical cancer.

Richard B.S. Roden, lead researcher for the new study and an associate professor at Johns Hopkins University, told Health Day news, "We have been trying to produce a single vaccine that would be able to protect patients against all cancer causing HPV types

A new study confirms earlier findings that human papillomavirus (HPV) DNA-based test are more accurate than Pap smears in finding precancerous tumors.

HPV test was known to detect more precancerous lesions than Pap smears (cytology) but it was not clear whether HPV test would lead to patient's treatment whose immune system would resist infections

A study from the Centers for Disease Control and Prevention estimates that 25 percent of the country's teenage girls, or almost 1 of 4 young girls, may have sexually transmitted diseases.

Girls aged 14 to 19 who are sexually active may have human papillomavirus (HPV), which is the leading cause of cervical cancer among women later in their lives. Other diseases are Chlamydia, trichomoniasis, and herpes simplex virus

The Centers for Disease Control and Prevention released a study Tuesday showing that one in every four adolescent girls in United States, aged between 14 and 19 years, has been infected with sexually transmitted disease (STD).

The authors of the study said that there were at least 3.2 million teenage girls between aged 14 and 19 currently infected with common STDs